NDC 71335-1514 – Buprenorphine HCl and Naloxone HCl

Buprenorphine Hydrochloride 2 mg/1; Naloxone Hydrochloride Dihydrate .5 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC71335-1514

Product details

Brand name
Buprenorphine HCl and Naloxone HCl
Generic name
Buprenorphine and Naloxone
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA203136
Marketed since
February 22, 2013
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine HCl and Naloxone HCl →

Package NDC codes (2)

Package NDCDescriptionSince
71335-1514-130 TABLET in 1 BOTTLE (71335-1514-1)Feb 17, 2020
71335-1514-210 TABLET in 1 BOTTLE (71335-1514-2)Sep 21, 2022

Other Buprenorphine HCl and Naloxone HCl products